A Modern Framework for Analytical Procedure Development and Lifecycle Management Based on ICH Q14 Principles.

Area of Science:

• Pharmaceutical Science
• Analytical Chemistry
• Regulatory Science

Background:

• Current analytical method validation relies on ICH Q2(R1) (2005) guidelines.
• Pharmaceutical submissions increasingly adopt holistic, risk-based control strategies.

Purpose of the Study:

• To present a strategy for implementing updated analytical method guidelines (ICH Q14/Q2(R2), USP ⟨1220⟩).
• To integrate key elements of ICH Q14 into an Analytical Quality by Design (AQbD) framework.

Main Methods:

• Exploration of current validation practices.
• Discussion of ICH Q14 elements: Analytical Target Profile (ATP), Knowledge Management, Risk Assessment, Performance Monitoring.
• Integration into an AQbD framework for development and lifecycle management.

Main Results:

• The proposed strategy aligns with lifecycle approaches and risk-based control strategies.
• Implementation requires balancing post-approval flexibility benefits with resource investment.
• The strategy aims to streamline analytical development and simplify method lifecycle management.

Conclusions:

• Adoption of ICH Q14/Q2(R2) and USP ⟨1220⟩ necessitates a lifecycle and AQbD approach.
• A risk-based strategy enhances method understanding and simplifies management.
• This transition promises more efficient and robust analytical procedures in the pharmaceutical industry.